<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00132236</url>
  </required_header>
  <id_info>
    <org_study_id>KA01096gms</org_study_id>
    <secondary_id>CTN980-CHC-9015-027</secondary_id>
    <nct_id>NCT00132236</nct_id>
  </id_info>
  <brief_title>Nurse Smoking Cessation of Patients With Chronic Obstructive Pulmonary Disease (COPD) With Nicotine Replacement Therapy (NRT) and Behavioral Support</brief_title>
  <official_title>Smoking Cessation of Patients With COPD: A Multi-Center, Randomized, Placebo Controlled Nurse Conducted Smoking Cessation Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <brief_summary>
    <textblock>
      This is a smoking cessation study with COPD patients where the researchers wanted to evaluate
      if nicotine sublingual tablets or placebo combined with low or high individual support could
      increase ½ and 1 year quit rates.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Placebo, controlled, randomized, double-blind trial with 400-1000 smoking COPD patients with
      FEV-1 &lt; 90 % predicted normal with the use of nicotine sublingual nicotine tablets or placebo
      for 12 weeks combined with individual clinic visits with low or high intensity conducted by
      trained nurses in several centres in pulmonary clinics in Denmark. Outcome was smoking
      cessation and smoking reduction after ½ and 1 year as self declared smoking status confirmed
      by carbon monoxide in expired air&lt; 10 ppm. Secondary outcomes were change in body-weight,
      quality of life (SF-36 and SGRQ), symptoms, lung function, adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>February 2002</start_date>
  <completion_date>June 2004</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>smoking cessation after 6 and 12 months</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>smoking reduction after 12 months</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in quality of life (St. George Respiratory Questionnaire)</measure>
  </secondary_outcome>
  <enrollment>300</enrollment>
  <condition>Smoking</condition>
  <condition>COPD</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nicotine sublingual tablets</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>low and high behavior support</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD patients (FEV1/FVC&lt;70% and FEV1&lt;90 % predicted)

          -  Smoking 1 cigarette daily or more

          -  Willing to follow the protocol

        Exclusion Criteria:

          -  Used NRT or bupropion the last week

          -  Not able or willing to adhere to the protocol

          -  Estimated survival &lt; 1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Tønnesen, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Pulm. dept. Gentofte University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. pulm. medicine, Århus kommunehospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. pulm. medicine, Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulm. Dept., Frederiksberg Hospital</name>
      <address>
        <city>Frederiksberg, Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulm. Dept, Gentofte University Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept of Pulm. medicine, Helsingør Sygehus</name>
      <address>
        <city>Helsingør</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. pulm. medicine, Nykøbing Falster Sygehus</name>
      <address>
        <city>nykøbing Falster</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulm. dept, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2005</study_first_submitted>
  <study_first_submitted_qc>August 17, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2005</study_first_posted>
  <last_update_submitted>October 20, 2005</last_update_submitted>
  <last_update_submitted_qc>October 20, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2005</last_update_posted>
  <keyword>smoking cessation</keyword>
  <keyword>nicotine sublingual tablets</keyword>
  <keyword>behaviour support</keyword>
  <keyword>smoking reduction</keyword>
  <keyword>quality of life</keyword>
  <keyword>COPD</keyword>
  <keyword>weight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

